Principal Investigator
Juan Alderuccio
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230696
Clinical Trial Summary
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647